Insider Selling: Teladoc Health, Inc. (NYSE:TDOC) Insider Sells $112,950.00 in Stock

Teladoc Health, Inc. (NYSE:TDOCGet Free Report) insider Arnnon Geshuri sold 7,500 shares of the stock in a transaction that occurred on Monday, March 25th. The stock was sold at an average price of $15.06, for a total value of $112,950.00. Following the sale, the insider now owns 38,470 shares in the company, valued at $579,358.20. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.

Teladoc Health Stock Performance

Shares of Teladoc Health stock opened at $15.10 on Friday. Teladoc Health, Inc. has a 12-month low of $14.29 and a 12-month high of $30.41. The company has a current ratio of 3.54, a quick ratio of 3.47 and a debt-to-equity ratio of 0.66. The business’s 50 day moving average is $17.51 and its 200-day moving average is $18.58.

Teladoc Health (NYSE:TDOCGet Free Report) last announced its quarterly earnings results on Tuesday, February 20th. The health services provider reported ($0.17) EPS for the quarter, beating analysts’ consensus estimates of ($0.22) by $0.05. Teladoc Health had a negative net margin of 8.47% and a negative return on equity of 9.22%. The firm had revenue of $660.50 million during the quarter, compared to analysts’ expectations of $670.79 million. During the same quarter last year, the company posted ($0.23) earnings per share. The company’s revenue for the quarter was up 3.6% compared to the same quarter last year. On average, equities research analysts predict that Teladoc Health, Inc. will post -1.07 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on TDOC shares. Royal Bank of Canada decreased their price objective on shares of Teladoc Health from $30.00 to $25.00 and set an “outperform” rating on the stock in a report on Wednesday, February 21st. Barclays lowered their price target on shares of Teladoc Health from $26.00 to $25.00 and set an “overweight” rating for the company in a report on Wednesday, February 21st. SVB Leerink assumed coverage on Teladoc Health in a report on Monday, February 26th. They set a “market perform” rating and a $17.00 price objective on the stock. DA Davidson cut their price objective on shares of Teladoc Health from $22.00 to $18.00 and set a “neutral” rating on the stock in a report on Wednesday, February 21st. Finally, Citigroup lowered their price target on Teladoc Health from $21.00 to $19.00 and set a “neutral” rating for the company in a research note on Wednesday, February 21st. Eight investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $22.43.

View Our Latest Report on TDOC

Institutional Investors Weigh In On Teladoc Health

Several hedge funds have recently added to or reduced their stakes in TDOC. Granite Bay Wealth Management LLC bought a new position in Teladoc Health during the 3rd quarter worth $3,675,000. Deutsche Bank AG raised its stake in Teladoc Health by 12.4% in the 3rd quarter. Deutsche Bank AG now owns 301,147 shares of the health services provider’s stock worth $5,598,000 after purchasing an additional 33,287 shares in the last quarter. QRG Capital Management Inc. acquired a new stake in Teladoc Health in the 3rd quarter worth about $392,000. Sherbrooke Park Advisers LLC bought a new stake in shares of Teladoc Health during the 3rd quarter valued at $680,000. Finally, Ergoteles LLC bought a new stake in Teladoc Health during the second quarter worth about $6,772,000. Institutional investors and hedge funds own 76.82% of the company’s stock.

Teladoc Health Company Profile

(Get Free Report)

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

Featured Stories

Insider Buying and Selling by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.